Moderna Receives FDA Authorization for Emergency Use of Omicron-Targeting Bivalent COVID-19 Booster Vaccine for Children and Adolescents 6 to 17 Years of AgeAccesswire • 10/12/22
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patientsCNBC • 10/12/22
Moderna Surges As Merck Inks Deal To Co-Develop Personalized Cancer Vaccine TreatmentInvestors Business Daily • 10/12/22
10 Fallen Growth Stocks Will Make You Up To 113% Richer, Analysts SayInvestors Business Daily • 10/12/22
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer VaccineAccesswire • 10/12/22
Is Moderna Stock A Buy After FDA Signs Off On Its Updated Covid Shot?Investors Business Daily • 10/03/22
2 Growth Stocks That Could Jump 64.1% to 86.1% Higher, According to Wall StreetThe Motley Fool • 10/03/22
Moderna refused China request to reveal vaccine technology, Financial Times reportsReuters • 10/02/22
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine MakerThe Motley Fool • 10/01/22
EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 BoosterZacks Investment Research • 09/29/22